secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2021-07-22T23:59:59+00:00
Accession:  0001096906-21-001665
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

UTMD Q2 net income up 161%, EPS $0.937; revenue $12.6M (+43%); guides FY EBITDA ~$25M
--------------------------------------------------------------------------------

- Q2 revenue $12.6M (+43% YoY); domestic +46%, OUS +40%; constant-currency sales +40%.
- GAAP EPS $0.937 (up 161%); non-GAAP (ex-UK DTL) EPS $1.044 (up 148%).
- Operating income $4.765M (+141%); gross margin 61.8% vs 56.3% a year ago.
- Management likely expects FY2021 adjusted EBITDA of ~$25M; TTM EBITDA $24.0M.
- Cash $59.5M, no debt; quarterly dividend $0.285/share (up from $0.280).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690621001665/0001096906-21-001665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690621001665/utmd-20210722.htm
  HTML page:      https://secwatch.observer/filing/0001096906-21-001665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer